IDX vs NUZ

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IDX

INTEG DIAG FPO [IDX]

47LOW

NUZ

NEURITHERA FPO [NUZ]

47LOW

Score Breakdown

IDX NUZ
Technical
63
50
Catalyst
50
50
Sentiment
50
50
Fundamental
91
48
Momentum
72
45
Risk Gate
34
50

Key Metrics

IDX Metric NUZ
$872.6MMarket Cap$57.4M
1.1MAvg Volume (20d)742K
+2.8%Short InterestN/A
$3.07052-Week High$0.185
$2.11052-Week Low$0.076
+0.4%Daily Change+1.2%
$2.370Entry Price$0.082
+2.1%ROE-147.1%
+1.8%Profit Margin-248.4%

Active Signals

IDX Signals

●Volume surging at 2.0x normal while price climbs — real buying conviction behind this move
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.1x)
●Strong revenue growth (+56%)
●EPS estimates revised upward (+10pts)

NUZ Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●Moderate P/S ratio (9.6x)
●Strong revenue growth (+290%)
●Near 52-week low (5% of range)

Ask Scout AI to compare IDX and NUZ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IDX Full Analysis → NUZ Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).